跳至主要内容
临床试验/JPRN-UMIN000006416
JPRN-UMIN000006416招募中未知

Preventive effects of Eicosapentaenoic acid (EPA) on stroke recurrence and a symptom state in chronic stroke patients with dyslipidemia. - Preventive effects of Eicosapentaenoic acid (EPA) on stroke recurrence and a symptom state in chronic stroke patients with dyslipidemia.

Tokyo Women's Medical University0 个研究点目标入组 100 人开始时间: 2011年9月30日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Following patients will be excluded from this study 1.SBP>=180mmHg or DBP>=110 2.Patirnts who are bleeding (Hemophilia, intracranial bleeding, Gastrointestinal bleeding, Urinary tract bleeding, Hemophysis, Vitreous hemorrhage) 3.Patients with known bleeding disorders or a predisposing condition 4.Severe liver or renal dysfunction 5.Malignancy 6.Scheduling the operation 7.Past history of severe adverse effect by Aspirin or Eicosapentaenoic Acid ethyl ester 8.Patients who are inadequate by physician's decision

研究者

发起方
Tokyo Women's Medical University

相似试验

Preventive effects of Eicosapentaenoic acid (EPA) on... | 临床试验